• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Baby Care OEM Manufacturer Handover Checklist: What Should Be Signed Off Before the First Shipment?

A baby care shipment is not released by a purchase order. It is released by a signed handover file — a set of approvals, test reports, and physical reference samples that prove the product…

Category: Mom & Baby Care Sourcing Guides • Author: laeyo • Published: 2026-11-01 • Views: 67

A baby care shipment is not released by a purchase order. It is released by a signed handover file — a set of approvals, test reports, and physical reference samples that prove the product inside the container is the product you approved. Because mom and baby care sits in the highest-scrutiny segment of personal care, the gap between “the samples looked great” and “the first shipment is releasable” is almost always documentation, not formula. This guide sets out the sign-offs to collect before the first shipment, what each one must prove, and the failure modes that usually only surface after the container has sailed.

What “Signed Off” Actually Means at Handover

A handover sign-off is not a courtesy signature on a shipping document. It is a three-layer confirmation, and each layer has a different owner:

  • Commercial layer — specification, quantity, packaging bill of materials, and delivery terms match the approved purchase order and version.
  • Technical layer — the executed batch record, first article inspection, and retained golden sample prove the production run matches the approved standard.
  • Compliance layer — testing, safety assessment, label content, and claims support are complete, current, and tied to the exact formula and artwork revision being shipped.

Practically, the handover page should carry signatures and dates from seven functions: project manager, R&D, production, quality/regulatory, purchasing/packaging, warehouse/logistics, and the final approver. If any of those boxes is signed by the same person “to save time,” the control has been removed, not streamlined.

Lock These Three Decisions Before You Discuss Anything Else

Most handover problems are created weeks earlier by leaving three decisions open too long. Sequence them deliberately:

  • Product form and claim set. A wipe, a wash, and a cream carry completely different test plans — preservative partitioning in a substrate, pH and tear-free substantiation in a wash, preservative efficacy and phase stability in a cream. Fixing the claim list early tells the lab which tests to schedule; changing it late restarts the clock.
  • Package route. Stock, semi-custom, or fully custom mold determines tooling lead time and how much compatibility testing is required. A new pump or a new wipes lid is a new variable, not a cosmetic swap.
  • Target market and responsible entity. The United States and the European Union place different obligations on the brand versus the factory. Decide who holds the responsible-person role, who files notifications, and therefore who owns which document before sampling starts.

Fastest safe path: lock formula direction, package route, and the claim list first; keep fragrance level, graphics, and secondary packaging as the later optimization levers. Those three can move without invalidating the micro, stability, or compatibility data. Formula and pack cannot.

Handover Sign-Off Table: What to Collect Before Release

Sign-off What it proves Who signs Evidence to file
Formula and specification lock The batch was made to a fixed, versioned target R&D + QA Signed spec sheet with revision code, pH, viscosity, actives, and effective date
Golden sample and pack combo approval Physical reference exists for comparison at any future reorder Buyer + R&D/QA Sealed retained sample, photos, component drawings, combo ID
Packaging compatibility and transit test Product and pack survive real use and real shipping Packaging supplier + QA Compatibility report (leak, pump/dropper function, label adhesion, weight loss) plus drop, compression, and high-temperature transit results
Artwork and label proof approval The printed label matches the approved formula version Regulatory + Buyer Final approved PDF with revision code, approval date, and print-proof photo
Claims substantiation matrix Every on-pack and listing claim has a test behind it Regulatory Claim-to-evidence table mapping each claim to a report number and date
Preservative efficacy and microbiology The product stays safe through use, not just at release Third-party lab Challenge test report, finished-product micro results, specification limits
Stability and shelf-life assignment The declared expiry date is supported by data, not assumption Lab + QA Accelerated and real-time protocol, interim report, signed shelf-life statement and storage conditions
Product safety assessment The formula has been assessed by a qualified safety assessor for the target market Safety assessor / Regulatory Signed safety report or product information file index, with assessor credentials
Batch record and QA release decision Nothing was shipped while a deviation or out-of-spec result was open Production + QA Executed batch record, deviation log, OOS/OOT status, traceability result, written release (not “hold”) decision
First article inspection and line clearance The filling line was verified before continuous production Production + QA FAI record covering SKU, formula, components, artwork, line clearance, fill weight, seal and appearance checks
Documentation pack and retained samples The brand can answer an auditor, a marketplace, or a customs officer later QA + Logistics COA per batch, SDS, invoice, packing list, batch-code traceability map, retention location and retention period

Red Lines: What Not to Cut to Hit a Launch Date

  • Never release with an open deviation or out-of-specification result. A batch on hold is a controlled batch; a batch released “pending paperwork” is an uncontrolled one.
  • Never skip preservative efficacy testing on a high-water baby product. Release data alone does not predict in-use survival.
  • Never approve artwork before the formula is locked. Ingredient order and allergen declarations follow the formula version, not the other way around.
  • Never substitute a “similar” pump, cap, or wipes lid without re-running compatibility and leak checks. Component equivalence is a tested conclusion, not an assumption.
  • Never ship without a batch-specific COA and SDS. A COA from a previous batch is a documentation failure, not a shortcut.
  • Never accept a verbal claims justification. If “tear-free,” “hypoallergenic,” or “pediatrician tested” appears on pack, a named report must exist in the file.
  • Never let retained samples be “discarded to save space.” Without a retained sample, no future batch can be compared to the approved standard.

Informational only, not legal advice. Confirm market-specific obligations with your regulatory specialist or responsible person.

Common Handover Failures and How to Prevent Them

1. Pump seizes or the cap weeps after two weeks

  • Symptom: Dispensing stiffens, product leaks at the closure, or the label lifts in a humid bathroom.
  • Root cause: No compatibility testing between the actual formula and the actual component; a supplier “equivalent” component was substituted after approval.
  • Prevention: Run compatibility and leak testing on the finished formula in the production component, and freeze the component supplier and version in writing.
  • What to request: Compatibility protocol and report, component drawings with supplier name and revision, leak and weight-loss data, label adhesion results after humidity exposure.

2. The COA does not match the batch that shipped

  • Symptom: Batch numbers on the COA, label, and packing list disagree; the INCI on pack reflects an earlier formula revision.
  • Root cause: Documents assembled from a template library instead of the executed batch record.
  • Prevention: Tie every document to a single batch code at release, and require a document reconciliation step before the container is loaded.
  • What to request: Batch-code traceability map, document checklist signed per batch, and label proof matched to the formula revision in force on the production date.

3. Preservative system fails in use, not at release

  • Symptom: Release micro is clean, but complaints or re-testing at week eight show growth — most often in wipes or in a product used with wet hands.
  • Root cause: No challenge test, or a challenge test run on a lab bench sample rather than the production formula in its final substrate.
  • Prevention: Require preservative efficacy testing on the production formula and, for wipes, partitioning data on the substrate.
  • What to request: Challenge test report with pass criteria, finished-product micro results per batch, and preservative specification with assay limits.

4. pH drift, phase separation, or colour change at 40 °C

  • Symptom: Product that looked correct at release separates or darkens within weeks of arrival.
  • Root cause: Stability was run on an earlier prototype, or only real-time data exists with no accelerated read-out before shipment.
  • Prevention: Freeze the formula before stability starts, and require an interim accelerated report before the first shipment rather than after.
  • What to request: Stability protocol with timepoints and conditions, interim report, and a written shelf-life and storage statement signed by QA.

5. A “tear-free” or “hypoallergenic” claim with nothing behind it

  • Symptom: Marketplace or retailer challenges the claim; the brand cannot produce a test report or a defensible rationale.
  • Root cause: Claims written by marketing after the label was designed, with no link to the test plan.
  • Prevention: Build the claim list before sampling, then map each claim to a specific test, method, and acceptance criterion.
  • What to request: Claim-to-evidence matrix, the underlying reports, and written confirmation of which claims the factory supports versus which remain the brand’s responsibility.

6. Label blocked at customs for missing responsible-party or allergen information

  • Symptom: Shipment held because the label lacks the responsible person or importer details, required language, net content format, or fragrance allergen declarations.
  • Root cause: Market requirements were treated as a design preference and confirmed after printing.
  • Prevention: Complete a market-specific label review against the locked formula, in the required language, before the print run is approved.
  • What to request: Signed label compliance review, allergen declaration list from the actual fragrance version, and a written split of responsibilities between factory and brand.

Email-Ready Handover Request

Subject: Pre-shipment handover pack – [Brand] / [PO number]

Share the locked formula and specification sheet with revision code and effective date.
Confirm the production component supplier, version, and drawing for bottle, pump, cap, and lid.
Provide the packaging compatibility report covering leak, dispensing function, and label adhesion.
Attach the drop, compression, and high-temperature transit test results.
Provide the preservative efficacy (challenge) test report and finished-product micro results.
Attach the stability protocol, interim report, and signed shelf-life and storage statement.
Provide the product safety assessment or product information file index for the target market.
Attach the claims substantiation matrix linking each claim to a report number.
Send the final approved artwork PDF with revision code and approval date.
Confirm the label review covers required language, responsible party, net content, and allergens.
Provide the executed batch record summary and line clearance record for this batch.
Confirm zero open deviations and zero open out-of-specification results.
State the QA release decision in writing (release or hold) with the approver name and date.
Attach the first article inspection record, including fill weight and seal checks.
Provide a batch-specific COA and the SDS for the finished product.
Send the batch-code traceability map linking components, bulk, filling, and cartons.
Confirm where retained samples are stored and the retention period.
List the shipping documents included in the carton and the contact for discrepancies.
Confirm which documents remain the brand's responsibility in the destination market.
Confirm the reorder lead time and the process for re-approval if any component changes.

Realistic Timeline and Evidence Outputs

  • Specification freeze (weeks 1–2). Buyer locks form, claims, and pack route. Factory issues a risk list. Evidence: signed spec sheet and project risk register.
  • Sampling and panel review (weeks 2–6). Factory produces candidates against the locked brief. Evidence: sample feedback form and shortlisted formula reference.
  • Testing window (weeks 4–14, overlapping). Stability, micro, challenge test, and compatibility run in parallel, not in sequence. Evidence: test protocols, interim reports, compatibility data.
  • Pilot run and first article (weeks 10–16). Line clearance and FAI confirm the line can make the product repeatedly. Evidence: pilot report and approved bulk standard sample.
  • Label and claims review (weeks 12–17). Regulatory check against the final formula version. Evidence: signed label review and claim matrix.
  • Documentation handoff and release (weeks 16–18). Full pack reconciled to batch codes. Evidence: complete handover file and written QA release.

Fastest safe path: run testing in parallel with pilot production and compress artwork rounds by freezing claims early — but do not compress the stability read-out, the challenge test, or the first article inspection. Standard path: sequence pilot, then testing, then label approval, which adds roughly three to four weeks and materially lowers the risk of a reprint or a held shipment.

FAQ

Can we ship before stability testing is finished?

Only with a documented, dated stability protocol, an interim accelerated report showing no failure, and a signed shelf-life assignment with a commitment to complete real-time data. Shipping with no stability data at all means the expiry date on pack is a guess, and that is difficult to defend if a customer or regulator asks.

Who actually has to sign the handover page?

Project management, R&D, production, quality/regulatory, purchasing or packaging, warehouse/logistics, and the final approver — each with a signature and a date. Consolidating these into one signature removes exactly the cross-checks the page exists to create.

What is the difference between US and EU documentation expectations?

For U.S. cosmetics, identify the label-defined responsible person and assess required facility registration and product listing, including applicable exemptions. A foreign facility required to register must designate a U.S. agent. The European Union centres on an EU responsible person, product notification before placing on the market, a product information file with a safety report, and GMP compliance. The factory typically supplies formula, safety, and batch documentation; the brand or importer typically owns the responsible-person role, notification, and final market-facing label. Never present a notification or listing as a certification or approval.

How long should the factory keep retained samples and records?

Ask for the written retention policy rather than a verbal answer, and align it to the strictest market you sell into — the EU, for example, expects the product information file to remain available for ten years after the last batch is placed on the market. Retained samples should cover at least the declared shelf life plus a margin, stored under labelled conditions.

What if only one SKU in the order is ready?

Release batch by batch, not order by order. Each SKU should carry its own QA release decision, its own COA, and its own document reconciliation. Partial shipment is acceptable; partial documentation is not.

Next Step

If you are sourcing baby wash, creams, wipes, or a mom-and-baby gifting set and want a handover pack built into the project plan from day one, start with a scoped request. Include your target market and responsible-entity plan, SKU count and formats, positioning (for example fragrance-free, tear-free, or clean-label), packaging direction (stock, semi-custom, or custom mold), and your launch window — those five inputs are what turn a general enquiry into a costed, test-planned quote. Request a Quote and ask for the pre-shipment handover checklist to be attached to your project brief.

Official sources: FDA registration and listing guidance.

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).